Clinical Trial

A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this Phase 3 clinical trial is to compare efficacy and safety of CT-P55 with Cosentyx in patients with moderate to severe plaque psoriasis
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-07.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-02-19
Trial Details
NCT Number NCT06630559
Lead Sponsor Celltrion
Conditions Plaque Psoriasis
Enrollment 153 participants
Start Date 2025-05-26
Primary Completion 2026-02-18 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-23